India Technology Sector Merger & Acquisition Filings — February 07, 2026

07-02-2026

Dr. Agarwals Health Care Ltd (BSE: 544350) has filed a disclosure under Regulation 10(5) of SEBI (SAST) Regulations, 2011, confirming receipt of an acquisition disclosure under Regulation 10(1)(a). No details on the acquirer, target specifics beyond the listed company, shares acquired, percentages, or deal value are provided in the filing. This is purely an informational SAST compliance filing with no quantitative or strategic details disclosed.

• ·Disclosure confirms an acquisition event in the listed company triggering SEBI SAST thresholds, but no share count, percentage change, or acquirer identity provided.

07-02-2026

BSE has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from/for Umiya Holding Pvt Ltd pertaining to Umiya Buildcon Ltd (BSE: 532376). The notice confirms receipt of the required SAST disclosure but provides no details on acquisition intention, stake thresholds, parties, valuation, or transaction structure. No quantitative metrics, financial impacts, or timelines are mentioned.

07-02-2026

BSE received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Sodhani Capital Ltd and Persons Acting in Concert (PACs) for Oasis Securities Ltd (512489). No quantitative details such as acquisition size, shareholding changes, valuation, or transaction terms were provided in the filing. This is an early-stage intimation of potential substantial acquisition.

07-02-2026

Sunshield Chemicals Ltd. (BSE: 530845) has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on February 07, 2026, pertaining to Swarna Malhotra & PACs. This disclosure indicates an intention to acquire shares potentially crossing specified thresholds (e.g., 25% or 5% increments). No quantitative details such as share count, percentage holdings, deal value, or transaction structure are mentioned.

07-02-2026

TTI Enterprise Limited (BSE: 538597) has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by BSE on February 07, 2026, pertaining to Kanakavally Prathapan. This filing indicates a change in shareholding that crossed specified disclosure thresholds, but no details on transaction direction, size, or impact are provided. No quantitative metrics, financial terms, or further context are disclosed.

07-02-2026

Euro Pratik Sales Limited (BSE: 544519) announced under SEBI LODR Regulation 30 its entry into a Joint Venture Agreement to form a new Joint Venture LLP, categorized as an Acquisition disclosure. No financial terms, deal size, parties beyond the JV entity, valuation, or strategic rationale details were disclosed in the announcement. This development in the technology sector is informational without quantified impacts.

07-02-2026

Arkade Developers Limited (BSE: 544261) has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding Arpit Vikram Jain. This indicates an intention to acquire shares that may cross substantial acquisition thresholds, but no details on deal structure, share count, percentage change, valuation, or other terms are provided in the filing. No quantitative financial metrics, parties beyond the named individual, or timelines are disclosed.

07-02-2026

Synthiko Foils Ltd. (BSE: 513307) announced under Regulation 30 of SEBI (LODR) Regulations, 2015, the incorporation of a wholly-owned subsidiary. No details such as subsidiary name, purpose, investment amount, strategic rationale, or financial implications were disclosed. This appears to be a routine corporate structuring event with no quantitative metrics or comparisons provided.

07-02-2026

BSE has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Pearls Dealers Pvt Ltd regarding Virtual Global Education Ltd (BSE: 534741). This filing indicates Pearls Dealers Pvt Ltd's intention to acquire shares or voting rights in the company, typically when approaching 5% threshold. No quantitative details such as stake size, valuation, consideration type, or timeline are disclosed.

07-02-2026

BSE received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Rajratan Investments Pvt Ltd pertaining to Rajratan Global Wire Ltd (517522). This filing indicates prior intimation of a potential substantial acquisition of shares, but no details on share count, percentage change, deal value, or transaction structure are provided. No financial metrics, synergies, or impacts are disclosed.

07-02-2026

Cybele Industries Ltd announced an update under Regulation 30 (LODR) on its acquisition activities, continuing from a letter dated 10/11/2025 intimating investment in wholly owned subsidiaries. No specific details on deal structure, parties, valuation, financial metrics, or impacts were disclosed. No quantitative data or performance metrics were provided, resulting in no identifiable positive or negative changes.

• ·Continuation of letter dated 10/11/2025 on investment in wholly owned subsidiaries

07-02-2026

Entero Healthcare Solutions Limited (BSE: 544122) issued an update on its acquisition on February 07, 2026, via BSE. No details on deal structure, parties involved, valuation, financial terms, or strategic rationale disclosed in the announcement. No quantitative metrics, positive or negative impacts, or scheduled events mentioned.

07-02-2026

Suraj Industries Limited (BSE: 526211) announced an acquisition under Regulation 30 of SEBI (LODR) Regulations, 2015. No details on deal structure, parties involved beyond the acquirer, valuation, consideration type, or strategic rationale were disclosed. No quantitative financial metrics, positive or negative changes, or flat performance indicators were provided in the announcement.